Which antibiotics are associated with an increased risk of serotonin syndrome?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 2, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Antibiotics Associated with Serotonin Syndrome

Linezolid is the primary antibiotic associated with serotonin syndrome due to its monoamine oxidase inhibitor (MAOI) properties, which can significantly increase serotonin levels when combined with other serotonergic medications. 1, 2

Mechanism and Risk

Linezolid acts as a reversible, nonselective monoamine oxidase inhibitor, which:

  • Inhibits the breakdown of serotonin in the central nervous system
  • Creates a high risk for serotonin syndrome when combined with other serotonergic medications
  • Plays a role in most cases of serotonin syndrome involving antibiotics 1

Other antibiotics with MAOI properties that may contribute to serotonin syndrome include:

  • Isoniazid (anti-tuberculosis agent) 1

Clinical Presentation of Serotonin Syndrome

Symptoms typically develop within 24-48 hours after combining medications and include:

  1. Mental status changes:

    • Confusion
    • Agitation
    • Anxiety
  2. Neuromuscular hyperactivity:

    • Tremors
    • Clonus (spontaneous or inducible)
    • Hyperreflexia
    • Muscle rigidity
  3. Autonomic hyperactivity:

    • Hypertension
    • Tachycardia
    • Arrhythmias
    • Tachypnea
    • Diaphoresis
    • Shivering
    • Vomiting
    • Diarrhea
  4. Advanced symptoms (potentially life-threatening):

    • Fever
    • Seizures
    • Arrhythmias
    • Unconsciousness 1, 3

High-Risk Medication Combinations

Linezolid should be used with extreme caution or avoided in patients taking:

  1. Antidepressants:

    • Selective Serotonin Reuptake Inhibitors (SSRIs) 1, 3, 4
    • Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs)
    • Tricyclic Antidepressants (TCAs)
    • Other antidepressants with serotonergic properties 1
  2. Opioid analgesics with serotonergic properties:

    • Tramadol (particularly high risk) 2
    • Meperidine
    • Methadone
    • Fentanyl 1, 5
  3. Other medications:

    • Dextromethorphan (in cough/cold medications)
    • Chlorpheniramine (in allergy medications)
    • Stimulants (amphetamines, methylphenidate) 1, 5
  4. Supplements:

    • St. John's Wort
    • L-tryptophan 1

Management Recommendations

When prescribing antibiotics to patients on serotonergic medications:

  1. First-line approach: Choose alternative antibiotics without MAOI properties whenever possible

  2. If linezolid is absolutely necessary:

    • Discontinue serotonergic medications if possible
    • Allow appropriate washout period (especially for fluoxetine)
    • Monitor closely for symptoms of serotonin syndrome, particularly in the first 24-48 hours
    • Consider consultation with clinical pharmacy
  3. For patients requiring pain management while on linezolid:

    • Avoid tramadol and other serotonergic opioids
    • Use non-serotonergic opioids such as morphine, codeine, oxycodone, or buprenorphine 2

Special Considerations

  • Bone marrow transplant recipients may be at higher risk for both serotonin syndrome and myelosuppression when receiving linezolid with SSRIs 6
  • Duration of overlap between linezolid and serotonergic medications increases risk - minimize concurrent use when possible 5
  • Patients with renal insufficiency may have increased risk due to altered drug clearance

Remember that serotonin syndrome is a clinical diagnosis requiring prompt recognition and intervention, as it can rapidly progress to life-threatening complications.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Serotonin Syndrome Risk with Tramadol and Linezolid

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Linezolid-Associated Serotonin Syndrome. A Report of Two Cases.

Journal of the American Podiatric Medical Association, 2015

Research

Myelosuppression and serotonin syndrome associated with concurrent use of linezolid and selective serotonin reuptake inhibitors in bone marrow transplant recipients.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2003

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.